These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2152304

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.
    Rezza G, Titti F, Pezzotti P, Sernicola L, Lo Caputo S, Angarano G, Lazzarin A, Sinicco A, Rossi GB, Verani P.
    J Biol Regul Homeost Agents; 1992; 6(1):15-20. PubMed ID: 1359736
    [Abstract] [Full Text] [Related]

  • 3. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [Abstract] [Full Text] [Related]

  • 4. [Serum adenosine deaminase in human immunodeficiency virus infection. Its relationship with CD4+ lymphocytes and beta 2-microglobulin].
    Iñigo MA, Ruiz López de Tejada M, Torres-Tortosa M, Sánchez-Porto A, Ugarte I, García de Lomas E, Morán Nestares A.
    Med Clin (Barc); 1992 Dec 12; 99(20):766-8. PubMed ID: 1361013
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical features of HIV infection in drug users of Manipur.
    Panda S, Kamei G, Pamei M, Sarkar S, Sarkar K, Singh ND, Deb BC.
    Natl Med J India; 1994 Dec 12; 7(6):267-9. PubMed ID: 7841877
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High beta2 microglobulin serum levels in human immunodeficiency virus infected intravenous drug addicts.
    Caruso L, Trischitta C, Russello M, Bertino G, Onorante A, Rapisarda S, Patania S, Tropeano L.
    J Chemother; 1989 Jul 12; 1(4 Suppl):1077-8. PubMed ID: 16312778
    [No Abstract] [Full Text] [Related]

  • 9. Beta 2-microglobulin levels in drug users: the influence of risk behaviour.
    Flegg PJ, Brettle RP, Robertson JR, Clarkson RC, Bird AG.
    AIDS; 1991 Aug 12; 5(8):1021-4. PubMed ID: 1777161
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.
    Portu JJ, Aldamiz-Etxebarria M, Agud JM, Arévalo JM, Almaraz MJ, Ayensa C.
    Addict Biol; 2002 Apr 12; 7(2):235-41. PubMed ID: 12006219
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of clinical symptoms of human immunodeficiency virus disease between intravenous drug users and homosexual men.
    Palenicek J, Nelson KE, Vlahov D, Galai N, Cohn S, Saah AJ.
    Arch Intern Med; 1993 Aug 09; 153(15):1806-12. PubMed ID: 8101438
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Trends in human immunodeficiency virus infection among drug users in a detoxification unit.
    Muga R, Sanvisens A, Egea JM, Tor J, Rey-Joly C.
    Clin Infect Dis; 2003 Dec 15; 37 Suppl 5():S404-9. PubMed ID: 14648455
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of hepatitis G virus RNA in human immunodeficiency virus type 1-positive intravenous drug users.
    Zehender G, De Maddalena C, Bosisio AB, Gianotto M, Santambrogio S, Moroni M, Galli M.
    J Hum Virol; 1998 Dec 15; 1(2):96-100. PubMed ID: 10195238
    [Abstract] [Full Text] [Related]

  • 17. Trends in HIV prevalence among drug-users attending public drug-treatment centres in Italy: 1990-2000.
    Suligoi B, Magliochetti N, Nicoletti G, Pezzotti P, Rezza G.
    J Med Virol; 2004 May 15; 73(1):1-6. PubMed ID: 15042640
    [Abstract] [Full Text] [Related]

  • 18. An analysis of the effects of HIV infection in a cohort of intravenous drug users.
    O'Kelly FD, Bury G.
    Ir Med J; 1996 May 15; 89(3):112-4. PubMed ID: 8707519
    [Abstract] [Full Text] [Related]

  • 19. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
    Guadagnino V, Zimatore G, Izzi A, Caroleo B, Rocca A, Montesano F, Costa C, Masciari R, Naso E, Biselli R.
    J Clin Lab Immunol; 1995 May 15; 47(1):1-9. PubMed ID: 8735431
    [Abstract] [Full Text] [Related]

  • 20. [Prevalence of human immunodeficiency virus (HIV)-Trypanosoma cruzi co-infection and injectable-drugs abuse in a Buenos Aires health center].
    Dolcini G, Ambrosioni J, Andreani G, Pando MA, Martínez Peralta L, Benetucci J.
    Rev Argent Microbiol; 2008 May 15; 40(3):164-6. PubMed ID: 19024504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.